Search

Author/Creator Meier, W

1. EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients. (1st November 2019)

Authors:
Klapdor, R; Hillemanns, P; Wölber, L; Jückstock, J; Hilpert, F; de Gregorio, N; Hasenburg, A; Sehouli, J; Fürst, ST; Strauß, HG; Baumann, K; Thiel, F; Mustea, A; Meier, W; Harter, P; Wimberger, P; Hanker, L; Schmalfeldt, B; Mahner, S
Journal:
International journal of gynecological cancer
Issue:
Volume 29(2019)Supplement 4
Page Start:
A605
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P193 p53 and p16 expression profiles identify three prognostically subgroups in vulvar cancer: a TMA based study by the AGO-CaRE-translational study group. (1st November 2019)

Authors:
Wölber, L; Prieske, K; Eulenburg, C; de Gregorio, N; Klapdor, R; Kalder, M; Braicu, I; Fuerst, S; Klar, M; Strauss, H-G; Mehlhorn, G; Meier, W; Ignatov, A; Mustea, A; Jueckstock, J; Schmidt, G; Bauerschlag, D; Hellriegel, M; Canzler, U; Luyten, A
Journal:
International journal of gynecological cancer
Issue:
Volume 29(2019)Supplement 4
Page Start:
A172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters—patient-centered end points in trials of maintenance therapy. (18th December 2017)

Authors:
Friedlander, M; Rau, J; Lee, C K; Meier, W; Lesoin, A; Kim, J -W; Poveda, A; Buck, M; Scambia, G; Shimada, M; Hilpert, F; King, M T; Debruyne, P; Bologna, A; Malander, S; Monk, B J; Petru, E; Calvert, P; Herzog, T J; Barrett, C
Journal:
Annals of oncology
Issue:
Volume 29:Number 3(2018)
Page Start:
737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗